1
0
0
News
IMBA und CeMM unter die internationalen Top 3 Arbeitsplätze für ...
www.bionity.com
Oder Oliver Hantschel, der nach seiner Zeit am CeMM eine Professur am renommierten EPFL in Lausanne übernahm. Kontakt / Infos anfordern. Fordern Sie gratis weitere Informationen an: Jetzt Infos anfordern. Merkliste ...
SFB-Seminar Oliver Hantschel - Veranstaltungskalender der Innsbrucker...
www.uibk.ac.at
Veranstaltungstyp: Gastvortrag;
Jäger, Klee, Mertsch und Wenzel für 50-jährige Treue geehrt ...
www.giessener-allgemeine.de
beiden Zweitplatzierten Klaus-Günther Mertsch und der an diesem Abend verhinderte Willi Braungart, die jeweils 73 Mal dabei waren, sowie Claudia Schäfer und Oliver Hantschel, die auf 72 Anwesenheiten zurückblicken ...
Preisverleihung an junge Krebsforscher
www.aerztezeitung.de
Dr. Christian Thieke optimierte die computergestützte Planung der intensitätsmodulierten Strahlentherapie und Dr. Oliver Hantschel erforschte ...
Netzwerk-Profile
LinkedIn: Oliver Hantschel – Full Professor – The Philipp University of ...de.linkedin.com › oliver-hantschel
Oliver Hantschel · Translational Cancer Researcher with expertise in biochemistry, drug action, structural biology and protein engineering. · Info · Aktivitäten ...
LinkedIn: Oliver Hantschel - Assistant Professor - EPFL (École ...
View Oliver Hantschel's profile on LinkedIn, the world's largest professional community. Oliver has 3 jobs listed on their profile. See the complete profile on ...
Bücher
Die Behandlung digitaler Inhalte im Gemeinsamen Europäischen ...google.de
books.google.de
HANSEN, HAUKE/ LIBOR, CHRISTINE HANSEN, HAUKE/ WOLFF-ROJCZYK, OLIVER HANTSCHEL, INES HARTMANN, THOMAS HAUG, THOMAS HEIDRICH, JOERG/ FORGÓ, ...
Protein Phosphorylation in Health and Diseasegoogle.de
books.google.de
... Sapienza University, Italy Reviewed by: Oliver Hantschel, École Polytechnique Fédérale de Lausanne, Switzerland Stephan Grzesiek, University of Basel, ...
Protein Phosphorylation in Health and Disease - Google Books
books.google.de
Protein phosphorylation is one of the most abundant reversible post-translational modifications in eukaryotes. It is involved in virtually all cellular...
AACR Proceedings: Abstracts google.de
books.google.de
Haijiao Zhang,1 Sophie Means,1 Anna R. Schultz,1 Kevin WatanabeSmith,1 Bruno C. Medeiros,2 Tim Kükenshöner,3 Oliver Hantschel ...
Dokumente zum Namen
SCHATTENBLICK - ONKOLOGIE/1258: Vielversprechende Sackgasse -...
www.schattenblick.de
Der Artikel "BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia" von Oliver Hantschel, Wolfgang Warsch, Eva ...
Mig6 Is a Sensor of EGF Receptor Inactivation that Directly Activates...
www.scienceopen.com
Authors: Sarah Hopkins,, Emma Linderoth,, Oliver Hantschel,, Paula Suarez-Henriques, Giulia Pilia, Howard Kendrick,, Matthew J. Smalley,, ...
EBSCOhost | | The structure of the leukemia drug imatinib...
web.a.ebscohost.com
Austria. Email: Jonathan A Winger - ; Oliver Hantschel - .ac.at; Giulio Superti-.
Wissenschaftliche Veröffentlichungen
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors...
bmccancer.biomedcentral.com
1 Jun 2012, Reviewed, Reviewer Report - Oliver Hantschel. 5 Jun 2012, Reviewed, Reviewer Report - Seiichi Okabe. Resubmission - Version Jul
New approach to fighting chronic myeloid leukemia -- ScienceDaily
www.sciencedaily.com
Chronic myeloid leukemia is caused by the hyperactivity of a mutated enzyme. Scientists have discovered an indirect way to regulate this enzyme that could...
The structure of the leukemia drug imatinib bound to human quinone...
bmcstructbiol.biomedcentral.com
Imatinib represents the first in a class of drugs targeted against chronic myelogenous leukemia to enter the clinic, showing excellent efficacy and specificity...
Veröffentlichungen allgemein
Allosterische Kinaseinhibitoren | SpringerLink
link.springer.com
Die Hemmung der Kinaseaktivität des BCR-ABL1-Onkoproteins durch einen allosterischen Wirkmechanismus eröffnet eine alternative Therapieoption f&#
The structure of the leukemia drug imatinib bound to human quinone...
link.springer.com
Imatinib represents the first in a class of drugs targeted against chronic myelogenous leukemia to enter the clinic, showing excellent efficacy and specificity...
Mechanisms of Activation of Abl Family Kinases | SpringerLink
link.springer.com
Oliver Hantschel (2); Giulio Superti-Furga (2). Author Affiliations. 2. Center for Molecular Medicine of the Austrian, Academy of Sciences, /3, ...
Oalib search
www.oalib.com
1947 ( 1 ). 1 ( 15 ). Search Results: of matches for " Oliver Hantschel " ... Jonathan A Winger, Oliver Hantschel, Giulio Superti-Furga, John Kuriyan
Artikel & Meinungen
Loseille
thiruvalluvar6.blog138.fc2.com
conte rinaldi · testi thursday · cnet linkedin · trident 57 · poetica pasolini · tipografia pancani oliver hantschel · grotta slovenia · avvocato blog · alternite firenze
A potent and highly specific FN3 monobody inhibitor of the Abl SH2...
www.nature.com
SH2 domains are present in many proteins, and designing specific inhibitors has been a challenge. Now a monobody, based on a fibronectin type III domain...
The SH2 domain of Abl kinases regulates kinase autophosphorylation by...
www.nature.com
The activity of protein kinases is regulated by multiple molecular mechanisms, and their disruption is a common driver of oncogenesis. A central and almost...
Sonstiges
Oliver Hantschel - Google Scholar
scholar.google.com
Assistant Professor, EPFL - mal zitiert - Biochemistry - Pharmacology - Molecular Medicine
Oliver Hantschel - Академия Google
scholar.google.co.uk
Assistant Professor, EPFL - цитирований - Biochemistry - Pharmacology - Molecular Medicine
Giulio Superti-Furga - Google Scholar
scholar.google.nl
Scientific Director, CeMM Research Center for Molecular Medicine of the Austrian Academy of - Geciteerd door - molecular medicine - chemical...
Oliver Hantschel
profi-parts.de
Betriebsleiter. Oliver Hantschel [javascript protected email address]
Dr. Oliver Hantschel - Labbnb
www.labbnb.com
Dr Oliver Hantschel and group study kinase mutations, especially BCR-ABL protein, which causes CML and some forms of B-cell acute lymphoblastic leukemia.
Oliver Hantschel | Swiss Institute for Experimental Cancer Research |...
biography.omicsonline.org
Oliver Hantschel studied biochemistry at the University of Regensburg and at Rockefeller University in New York City. He received his PhD in from the...
Karel Dorey - Google Scholar
scholar.google.co.uk
Lecturer, University of Manchester - Cited by - Regeneration - Signalling - Spinal Cord - Developmental Biology
Keiryn L. Bennett - Google Scholar
scholar.google.at
sciGig Scientific Consulting & Editing e.U. - Cited by - proteomics-mass spectrometry
Keiryn L. Bennett - Google Scholar Citations
scholar.google.at
Oliver Hantschel · Tilmann Bürckstümmer · Florian P Breitwieser · Florian Grebien · Angela Bauch · Alexandre Podtelejnikov · Matthias Mann · Karl Mechtler
Leukämie-Online - Leukämie-Online
www.leukaemie-online.de
Leukämie-Online, die Online-Gemeinschaft von Patienten für Patienten mit Leukämie und deren Angehörige
2 Research Assistants (PhD student positions) | EURAXESS ...www.euraxess.de › node
www.euraxess.de
Dr. Oliver Hantschel is currently accepting applications for 2 Research Assistants (PhD student positions) The positions are offered for a period ...
Dissection of the BCR-ABL signaling network using highly specific...
www.chemie.de
Autoren: Fern Sha; Emel Basak Gencer; Sandrine Georgeon; Akiko Koide; Norihisa Yasui; Shohei Koide; Oliver Hantschel. Journal: Proceedings of the National ...
Tilmann Bürckstümmer - Google Scholar
scholar.google.de
Aelian Biotechnology - mal zitiert - CRISPR - Screening - Human Genetics - Genome Editing
BCR-ABL SH3-SH2 domain mutations in chronic myeloid ...ohsu.pure.elsevier.com › bcr-abl-s...
ohsu.pure.elsevier.com
Daniel W. Sherbenou, Oliver Hantschel, Ines Kaupe, Stephanie Willis, Thomas Bumm, Lalita P. Turaga, Thoralf Lange, Kim Hien Dao, Richard ...
Discovery reveals potential approach to treat CML | MDedge ...www.mdedge.com › article › disco...
www.mdedge.com
Oliver Hantschel, PhD, of the École polytechnique fédérale de Lausanne (EPFL) in Lausanne, Switzerland, and his colleagues described this ...
Heidelberger Life-Science Lab
www.life-science-lab.org
Dr. Oliver Hantschel, Forschungszentrum f. molekulare Medizin, Wien. Prof. Dr. Andrei Lupas, MPI f. Entwicklungsbiologie, Tübingen. Dipl.- Biol. Tobias Stuwe ...
Harvard - Haematologicahaematologica.org › get › harvard-...
haematologica.org
Oliver Hantschel (2012) “Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug ...
ISREC Stiftung - Auftrag - Fondation ISRECftp.isrec.ch › projets_soutenus_detail_eid_18_lid_2
ftp.isrec.ch
Forschungslabore Forschungsgruppe von Prof. Oliver Hantschel, ISREC@EPFL. Einleitung Das Hantschel Labor begann seine Arbeit vor zweieinhalb Jahren ...
Swiss Medical Weekly - Monobodies as possible next-generation protein...
smw.ch
Oliver Hantschel, PhD, Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École polytechnique fédérale de ...
ALSA 2008: Neuer Frauenrekord bei Bewerbern | Chemiereport
www.chemiereport.at
Weiters nominiert waren das Forscherteam Dr. Oliver Hantschel und Dr. Tilmann Bürckstümmer vom Zentrum für Molekulare Medizin der ...
Verwandte Suchanfragen zu Oliver Hantschel
| Stephan Grzesiek Wolfgang Warsch Giulio Superti-Furga |
Person "Hantschel" (3) Vorname "Oliver" (42674) Name "Hantschel" (185) |
sortiert nach Relevanz / Datum